跳至主要内容
临床试验/ISRCTN66618743
ISRCTN66618743已完成未知

Intravenous versus subcutaneous immunoglobulin therapy in multifocal motor neuropathy

Academic Medical Centre (AMC) (The Netherlands)0 个研究点目标入组 10 人开始时间: 2007年6月27日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
10

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. All adult patients (greater than 18 years) with signs and symptoms consistent with MMN that fulfill the European Federation of Neurological Societies/Peripheral Nerve Society (EFNS/PNS) criteria for definite MMN and are being treated with IVIg for at least six months at regular intervals of at most six weeks
  • 2. Patients have to have stable disease for at least six months before inclusion

排除标准

  • 1. Use of drugs which are known to cause motor neuropathy
  • 2. Patient and/or partner is/are unable to administer SCIg at home
  • 3. Other diseases known to cause neuropathy or to reduce mobility
  • 4. Diseases known to lead to severe handicap or death at short notice
  • 5. A known selective Immunoglobulin A (IgA) deficiency with anti-IgA antibodies
  • 6. Refusal to give informed consent or withdrawal of previously given permission
  • 7. Legally incompetent adult

研究者

发起方
Academic Medical Centre (AMC) (The Netherlands)

相似试验